All ProductsDisplaying Products Alphabetically by Name (D)
Cat. No. | Product Name / Activity |
---|---|
2902 | D 4476 |
Selective CK1 inhibitor. Also inhibits TGF-βRI | |
1437 | D609 |
Selective PC-PLC inhibitor | |
7444 | DA ZP1 |
Fluorogenic Zn(II) sensor for isolation of stem cell derived β cells | |
3790 | DADLE |
Prototypical δ agonist | |
7756 | DAF FM diacetate |
Cell permeable photostable nitric oxide (NO) fluorescent indicator | |
1171 | DAMGO |
Selective μ agonist | |
0482 | 4-DAMP |
Muscarinic M3 antagonist | |
5748 | DAPI |
Blue-fluorescent DNA stain / dye. Used for: nuclear counterstain, fixed and live-cell staining, assessing apoptosis. Application: flow cytometry, confocal microscopy, immunofluorescence (IHC, ICC), ISH | |
2634 | DAPT |
γ-secretase inhibitor; induces neuronal differentiation; blocks Notch signaling | |
TB2634-RMU | DAPT |
DAPT synthesized to Ancillary Material Grade | |
2096 | DAU 5884 hydrochloride |
M3 receptor antagonist | |
7480 | DBCO PEG4 Biotin |
Biotinylation reagent for labeling azide-containing biomolecules via Cu(I)-free click chemistry | |
7921 | DBCO-NHS |
Amine reactive and azide reactive building block | |
6175 | DBHDA |
Reagent for synthetic biology; converts cysteine to dehydroalanine | |
5095 | DBM 1285 dihydrochloride |
p38 MAPK inhibitor; anti-inflammatory | |
4489 | DBZ |
γ-secretase inhibitor; inhibits Notch pathway | |
5357 | DC 260126 |
FFA1 (GPR40) antagonist | |
6873 | DC 271 |
Fluorescent retinoic acid analog; solvochromatic probe | |
7176 | DC-Cholesterol hydrochloride |
Cationic cholesterol derivative | |
2755 | DCA |
Mitochondrial pyruvate dehydrogenase kinase (PDK) inhibitor | |
1422 | DCEBIO |
Activates Cl- conductance and hKCa3.1 channels | |
0975 | DCG IV |
Highly potent group II mGlu agonist; also NMDA agonist | |
7285 | DCLK1-IN-1 |
Potent and selective doublecortin like kinase 1/2 (DCLK1/2) inhibitor; orally bioavailable | |
2137 | 2,3-DCPE hydrochloride |
Selectively induces cancer cell apoptosis | |
1302 | (S)-3,4-DCPG |
Potent and selective mGlu8a agonist | |
1540 | DCPIB |
Blocker of VRAC/ICl, swell | |
7160 | DD 03-171 |
Potent and selective BTK Degrader (PROTAC®) | |
5077 | DDR1-IN-1 dihydrochloride |
Selective DDR1 inhibitor | |
2558 | 10-DEBC hydrochloride |
Selective Akt/PKB inhibitor | |
5774 | DEL 22379 |
ERK dimerization inhibitor | |
8009 | Z-DEVD-FMK Caspase-3 Inhibitor |
Caspase-3 Inhibitor | |
5609 | DFHBI |
GFP fluorophore mimic for imaging RNA in living cells; activated by binding Spinach2 and Broccoli aptamers | |
5610 | DFHBI 1T |
GFP fluorophore mimic for imaging RNA in living cells; activated by binding Spinach2 and Broccoli aptamers | |
6434 | DFHO |
RFP fluorophore mimic for imaging RNA in living cells; activated by binding Corn aptamers | |
2761 | DFMO |
Ornithine decarboxylase inhibitor | |
6240 | DG 041 |
Potent and selective EP3 antagonist; antiplatelet and antithrombotic | |
0112 | γDGG |
Broad spectrum glutamatergic antagonist | |
1218 | DH 97 |
MT2 receptor antagonist | |
4599 | 3,5-DHBA |
Selective HCA1 agonist | |
8168 | DHC-156 New |
Brachyury down modulator | |
0342 | (RS)-3,5-DHPG |
Selective group I mGlu agonist | |
0805 | (S)-3,5-DHPG |
Selective group I mGlu agonist; active enantiomer of 3,5-DHPG (Cat. No. 0342) | |
4523 | DIDS |
Chloride channel blocker; TRPV1 modulator; RAD51 recombinase inhibitor | |
6377 | DIM-C-pPhOH |
Nur77 antagonist | |
0794 | DIPPA hydrochloride |
Selective and irreversible κ antagonist | |
7082 | DL 175 |
Potent and selective GPR84 agonist | |
3154 | DL-Dithiothreitol |
Maintains SH groups in the reduced state | |
7946 | DLin-MC3-DMA |
Component of lipid nanoparticles (LNPs); ionizable cationic lipid | |
3083 | DMCM hydrochloride |
Benzodiazepine inverse agonist | |
7944 | DMG-PEG 2000 |
PEGylated myristoyl diglyceride; commonly used in the formation of lipid nanoparticles (LNPs) | |
4126 | DMH-1 |
Selective ALK2 inhibitor | |
5580 | DMH2 |
Type I BMP receptor inhibitor | |
7764 | DMHBO+ |
Fluorescent upon binding to Chili aptamer; for imaging RNA in cells | |
6315 | DMNB-caged-Serine |
Caged serine; excited by visible blue light | |
5948 | DMNPE-4 AM-caged-calcium |
Calcium cage; cell permeable | |
5157 | DMNPE-caged ATP diammonium salt |
Caged ATP | |
4408 | DMOG |
Prolyl hydroxylase inhibitor | |
1222 | DMPQ dihydrochloride |
Potent, selective inhibitor of PDGFRβ | |
3176 | DMSO, sterile filtered |
DMSO, sterile filtered, wide ranging applications in cell culture, cryopreservation and organic chemistry. Solvent for polar and nonpolar compounds | |
7726 | DMSO, Cell Cryopreserve Grade |
Intracellular cryoprotective agent | |
5601 | DMXAA |
mSTING agonist; induces antitumor immunological responses | |
0189 | DNQX |
Selective non-NMDA iGluR antagonist | |
2312 | DNQX disodium salt |
Selective non-NMDA iGluR antagonist; water-soluble salt of DNQX (Cat. No. 0189) | |
7175 | DOPE |
Liposome/lipoplex transfection enhancer | |
7179 | DOTAP |
Cationic agent for liposome and LNP formation | |
0439 | DPCPX |
Selective A1 antagonist | |
1431 | DPDPE |
Selective δ agonist | |
1494 | DPN |
Highly potent ERβ agonist | |
2533 | DPO-1 |
Blocker of KV1.5 channel and IKur current | |
2783 | DPPI 1c hydrochloride |
Dipeptidyl peptidase IV (DPP-IV) inhibitor | |
6903 | DPTIP |
Potent and selective N-SMase2 inhibitor; brain penetrant | |
7628 | DPTN |
Potent and selective A3 adenosine receptor antagonist | |
4491 | DQP 1105 |
GluN2C/GluN2D-selective NMDA antagonist | |
5005 | DR 4485 hydrochloride |
High affinity and selective 5-HT7 antagonist; orally bioavailable | |
5548 | DREADD agonist 21 |
Potent hM3Dq and hM4Di DREADD agonist; blood brain barrier penetrant | |
6422 | DREADD agonist 21 dihydrochloride |
Potent hM3Dq and hM4Di DREADD agonist; water soluble version of DREADD agonist 21 (Cat. No. 5548) | |
3610 | (R)-DRF053 dihydrochloride |
Potent CK1 inhibitor; also inhibits cyclin-dependent kinases | |
3679 | DS2 |
Positive allosteric modulator of GABAA receptors; displays subunit selectivity | |
2958 | DSP-4 |
Adrenergic neurotoxin | |
7943 | DSPC |
Neutral phospholipid; component of lipid nanoparticles (LNPs) | |
7947 | DSPE-PEG 2000 Maleimide |
PEGylated DSPE with a maleimide reactive group | |
4809 | DSR 6434 |
Potent TLR7 agonist | |
7414 | DSRM-3716 |
Potent and reversible SARM1 NAD hydrolase inhibitor | |
8070 | DX3-213B |
Potent NDUFS7 antagonist | |
5656 | DY 268 |
Potent FXR antagonist | |
2266 | DY131 |
Agonist selective for estrogen-related receptors ERRβ and ERRγ | |
TB4703-RMU | DZNep HCl |
3-Deazaneplanocin A hydrochloride synthesized to Ancillary Material Grade | |
7223 | Dabrafenib mesylate |
Potent and selective B-Raf, CDK16 and NEK9 inhibitor; anticancer; also targets human proteins in the SARS-CoV-2 interactome | |
6231 | Dacomitinib |
Potent irreversible pan ErbB inhibitor | |
0507 | Dantrolene, sodium salt |
Ca2+ release inhibitor | |
6902 | Dapansutrile |
NLRP3 inflammasome inhibitor; disrupts inflammasome formation | |
3917 | Daptomycin |
Antibiotic; inhibits protein, DNA and RNA synthesis in gram-positive bacteria | |
6755 | Darapladib |
Potent lp-PLA2 inhibitor | |
6710 | Darunavir |
Highly potent HIV protease inhibitor | |
6793 | Dasatinib |
Highly potent pan-Src/Bcr-Abl inhibitor | |
1467 | Daunorubicin hydrochloride |
DNA topoisomerase II inhibitor | |
6779 | Davunetide |
Highly potent active component of ADNP; prevents amyloid β aggregation; active in vivo | |
4488 | 1-Deazaadenosine |
Adenosine deaminase inhibitor | |
4703 | 3-Deazaneplanocin A hydrochloride |
EZH2 histone methyltransferase inhibitor | |
3501 | Decanoyl-RVKR-CMK |
Subtilisin/Kex2p-like proprotein convertase inhibitor | |
2624 | Decitabine |
DNA methyltransferase inhibitor | |
7305 | Defactinib |
Potent and selective FAK and Pyk2 inhibitor | |
5764 | Deferoxamine mesylate |
Iron chelator; also hypoxia mimetic and neuroprotectant | |
5424 | Deltarasin |
High affinity PDEδ-KRas interaction inhibitor; binds to PDEδ | |
1180 | [D-Ala2]-Deltorphin II |
Selective δ agonist peptide | |
1819 | Demethylasterriquinone B1 |
Selective insulin RTK activator | |
4515 | 2-Deoxy-D-glucose |
Non-metabolizable glucose analog; inhibits glucose metabolism | |
3976 | Deoxynivalenol |
Mycotoxin; potent protein synthesis inhibitor | |
7193 | Deschloroclozapine |
High affinity and highly potent activator of hM3Dq and hM4Di DREADDs; rapidly blood brain barrier penetrant | |
3328 | Desformylflustrabromine hydrochloride |
Positive allosteric modulator of α4β2 nAChRs; also muscle-type nAChR inhibitor | |
3067 | Desipramine hydrochloride |
Selective inhibitor of noradrenalin transporters | |
3396 | Desmopressin |
Synthetic vasopressin analog; V1B and V2 agonist | |
2304 | Devazepide |
Selective, orally active CCK1 receptor antagonist | |
1126 | Dexamethasone |
Anti-inflammatory glucocorticoid | |
TB1126-RMU | Dexamethasone |
Dexamethasone synthesized to Ancillary Material Grade | |
2695 | Dexfenfluramine hydrochloride |
5-HT reuptake inhibitor; also stimulates 5-HT release | |
2749 | Dexmedetomidine hydrochloride |
Potent, highly selective α2 agonist. Active isomer of medetomidine (Cat. No. 5160) | |
3857 | Dexrazoxane hydrochloride |
Topoisomerase II inhibitor | |
7324 | Di 4 ANEPPS |
Voltage-sensitive probe; used to detect changes in membrane potential in electrophysiology protocols | |
5702 | DiD perchlorate |
Lipophilic fluorescent dye. Used for: membrane labeling. Application: fluorescent microscopy, flow cytometry. Suitable for live cell imaging | |
6882 | DiFMUP |
Fluorescent phosphatase substrate | |
0964 | Diazoxide |
Inhibits AMPA desensitization | |
1141 | Dibutyryl-cAMP, sodium salt |
Cell-permeable cAMP analog | |
0286 | 5,7-Dichlorokynurenic acid |
Potent NMDA antagonist; acts at glycine site | |
3698 | 5,7-Dichlorokynurenic acid sodium salt |
Potent NMDA antagonist, acts at glycine site; sodium salt of 5,7-Dichlorokynurenic acid | |
4454 | Diclofenac sodium salt |
Cyclooxygenase inhibitor; NSAID | |
0468 | N1,N11-Diethylnorspermine tetrahydrochloride |
Spermine and spermidine acetyltransferase potentiator | |
7236 | Digoxigenin Tyramide |
Reagent used for Tyramide Signal Amplification in IHC, ICC and ISH | |
4583 | Digoxin |
Na+/K+ ATPase inhibitor | |
0884 | Dihydrexidine hydrochloride |
Selective D1-like agonist | |
2349 | Dihydro-β-erythroidine hydrobromide |
α4β2, muscle type and Torpedo nAChR antagonist | |
0475 | Dihydroergotamine mesylate |
α partial agonist; also D2-like partial agonist and 5-HT antagonist | |
0111 | Dihydrokainic acid |
EAAT2 (GLT-1)-selective non-transportable inhibitor of L-glutamate and L-aspartate uptake | |
3826 | 7,8-Dihydroxyflavone |
TrkB agonist | |
0481 | Dilazep dihydrochloride |
Adenosine uptake inhibitor | |
0685 | Diltiazem hydrochloride |
CaV1.x blocker | |
1425 | (S)-(+)-Dimethindene maleate |
Selective M2 antagonist | |
4027 | 16,16-Dimethyl Prostaglandin E2 |
Synthetic prostaglandin E2 (Cat. No. 2296) derivative; regulates HSC development | |
7336 | Dinaciclib |
Potent and selective inhibitor of CDK2, CDK5, CDK1 and CDK9 | |
3072 | Diphenhydramine hydrochloride |
H1 antagonist | |
0504 | Diphenyleneiodonium chloride |
GPR3 agonist; also inhibits NOS and NADPH oxidases | |
6019 | Diprotin A |
Dipeptidyl peptidase IV (DPP-IV) inhibitor | |
0691 | Dipyridamole |
Adenosine transport inhibitor | |
7768 | Disulfide biotin azide |
Azide-activated biotinylation reagent; labels alkyne moieties via copper-catalyzed click chemistry | |
3807 | Disulfiram |
Reversibly stimulates SERCA Ca2+-ATPase; displays a range of other activities | |
0515 | Dobutamine hydrochloride |
α1, β1 and β2 agonist | |
4056 | Docetaxel |
Microtubule stabilizer | |
3687 | Docosahexaenoic acid |
RXR agonist | |
3757 | Dofetilide |
KV11.1 (hERG) channel blocker; inhibits rapid delayed rectifier K+ current (IKr) | |
4385 | Donepezil hydrochloride |
Potent AChE inhibitor | |
6568 | Dooku 1 |
Reversibly blocks Yoda1 activity; does not affect constitutive Piezo1 activity | |
3548 | Dopamine hydrochloride |
Endogenous agonist at dopamine D1-5 receptors | |
3093 | Dorsomorphin dihydrochloride |
Potent AMPK inhibitor; also BMP type I receptor inhibitor | |
2964 | Doxazosin mesylate |
α1 antagonist | |
2252 | Doxorubicin hydrochloride |
Antitumor antibiotic agent. Inhibits DNA topoisomerase II | |
4090 | Doxycycline hyclate |
Broad-spectrum MMP inhibitor; tetracycline derivative | |
1430 | DuP 697 |
Cyclooxygenase-2 (COX-2) inhibitor | |
4798 | (S)-Duloxetine hydrochloride |
Potent 5-HT and NA reuptake inhibitor (SNRI); also blocks dopamine reuptake | |
6896 | Dynapyrazole A |
Hedgehog signaling inhibitor; dynein inhibitor | |
6526 | Dynarrestin |
Inhibitor of Hedgehog (Hh) signaling; inhibits cytoplasmic dynein | |
2897 | Dynasore |
Non-competitive dynamin inhibitor | |
4222 | Dynole 34-2 |
Dynamin I inhibitor | |
3195 | Dynorphin A |
Endogenous κ agonist |
Tocris Products by Catalog Number
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800